Milnacipran is a serotonin/norepinephrine reuptake inhibitor (SNRI) antidepressant. It is used in the treatment of depression and has demonstrated significant improvements in multiple aspects of fibromyalgia, including pain, patient global assessment and physical function.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Fibromyalgia | 106 |
|
|
|
|
|
39 |
| Pain | 12 |
|
|
|
4 | ||
| joint pain | 6 |
|
1 | ||||
| to get relief | 5 | 0 | |||||
| Other | 4 |
|
1 | ||||
| Treat my mood condition(s) | 4 | 0 |
See all 153 patients currently taking Milnacipran
Mouse over the table for more information
Top 10 dosages based on patients currently taking Milnacipran. See all 17 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Side effects too severe
|
21 | 62% |
|
|
Did not seem to work
|
9 | 26% |
|
|
Doctor's advice
|
8 | 24% |
|
|
Expense
|
2 | 6% |
|
|
Other
|
2 | 6% |
|
Report created on November 21, 2009.